Latest Gastrointestinal Podcast Episodes
Current Clinical Practice and NCCN Guidelines for CLL/SLL
CCO Oncology Podcast - July 18, 2024 20:07 - 31 minutesIn this podcast episode, Farrukh Awan, MD, Jeremy S. Abramson, MD, MMSc, and Shuo Ma, MD, PhD, discuss real-world patient cases and how to align current clinical practice with the NCCN guidelines for CLL/SLL, including: Prognostic variables when deciding between regimens Role of MRD in CLL Re...
Congress to Clinic: Expert Takeaways on Emerging Data for MPNs
CCO Oncology Podcast - July 12, 2024 04:00 - 28 minutesIn this episode, listen to Dr Brady L. Stein share his clinical insights and takeaways on new data for myeloproliferative neoplasms (MPNs) presented at the 2024 ASCO Annual Meeting and the EHA 2024 Congress including: Long-term survival adjusted for treatment crossover in patients with myelofib...
CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways
CCO Oncology Podcast - July 11, 2024 15:58 - 24 minutesIn this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including: Rationale for targeting CELMoDs in NHL Mechanism of action of CELMoDs Key studies and available efficacy and safety data with investigational CELMoDs in NHL K...
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
CCO Oncology Podcast - July 09, 2024 19:28 - 24 minutesIn this episode, Dr Joyce O’Shaughnessy moderates a discussion with Dr Sara Hurvitz and Dr Erica Mayer answering audience questions on the latest data on incorporating CDK4/6 inhibitors into treatment plans for patients with HR+/HER2- breast cancer. Topics in this podcast include: Evidence fro...
Congress to Clinic: Expert Takeaways on Emerging Data for AML
CCO Oncology Podcast - July 08, 2024 04:00 - 25 minutesIn this episode, listen to Professor Eunice S. Wang, MD, share her clinical insights and takeaways on new data for acute myeloid leukemia (AML) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: Data from the prospective, single-center phase Ib/II study of FLAG-IDA p...
Congress to Clinic: Expert Takeaways on Emerging Data for MDS
CCO Oncology Podcast - July 05, 2024 14:22 - 19 minutesIn this episode, listen to Professor Courtney DiNardo, MD, MSCE, share her clinical highlights and clinical takeaways on new data for myelodysplastic syndromes (MDS) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: COMMANDS trial of luspatercept in transfusion-dep...
Experiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer
CCO Oncology Podcast - May 14, 2024 04:00 - 25 minutesIn this episode, Manali Bhave, MD; Annalise Labatut, PharmD, BCOP; and nurse practitioner Jamie L. Carroll, CNP, APRN, MSN, begin by discussing the landmark EMERALD study that led to FDA approval of elacestrant, the first oral selective estrogen receptor degrader (SERD) for treatment of hormone ...
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
CCO Oncology Podcast - May 07, 2024 16:44 - 47 minutesIn this episode, Danielle M. Brander, MD; Deborah Stephens, DO; and Brian Hill, MD, PhD, discuss key aspects of the NCCN CLL guidelines and share strategies for applying these recommendations in your clinical practice to optimize treatment and outcomes. The greater discussion addresses: Optimal...
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
Gastrointestinal Cancer Update - May 03, 2024 20:10 - 59 minutes ★★★ - 1 ratingProf Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer.
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
Gastrointestinal Cancer Update - May 03, 2024 20:10 - 59 minutes ★★★★ - 17 ratingsProf Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer.
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
Gastrointestinal Cancer Update - May 03, 2024 20:10 - 59 minutes ★★★★★ - 4 ratingsProf Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer.
Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
Gastrointestinal Cancer Update - April 16, 2024 16:57 - 37 minutes ★★★★ - 17 ratingsDr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal cancer.
Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
Gastrointestinal Cancer Update - April 16, 2024 16:57 - 37 minutes ★★★★★ - 4 ratingsDr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal cancer.
Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
Gastrointestinal Cancer Update - April 16, 2024 16:57 - 37 minutes ★★★ - 1 ratingDr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal cancer.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
Gastrointestinal Cancer Update - April 08, 2024 16:59 - 58 minutes ★★★ - 1 ratingProfessor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
Gastrointestinal Cancer Update - April 08, 2024 16:59 - 58 minutes ★★★★★ - 4 ratingsProfessor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer.
Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer
CCO Oncology Podcast - March 28, 2024 16:28 - 48 minutesIn this episode, Colin C. Pritchard, MD, PhD, a pathologist, and Heather H. Cheng, MD, PhD, a medical oncologist, discuss optimal biomarker testing to guide treatment decisions in advanced prostate cancer, with topics including: Rationale for targeting PARP in prostate cancer with ARI combinat...
EP 54 | This is Your Body on Carbs: Tips to Build Carb “Tolerance” with IBS
SIBO Made Simple - March 27, 2024 17:38 - 36 minutes ★★★★★ - 365 ratingsThe podcast is back for a very special two-part bonus episode series dedicated to the subject of carbs and IBS. Which also just so happens to be the subject of my new cookbook! On the last episode, I explained the role of carbohydrates in our digestive process and their impact on metabolic hea...
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
Gastrointestinal Cancer Update - March 21, 2024 15:43 - 1 hour ★★★ - 1 ratingDr Robin K (Katie) Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Mark Yarchoan from the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, Maryland, discuss clinical decision-making with numerous treatment strategies for hepatocellu...
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
Gastrointestinal Cancer Update - March 21, 2024 15:43 - 1 hour ★★★★★ - 4 ratingsDr Robin K (Katie) Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Mark Yarchoan from the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, Maryland, discuss clinical decision-making with numerous treatment strategies for hepatocellu...
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
Gastrointestinal Cancer Update - March 21, 2024 15:43 - 1 hour ★★★★ - 17 ratingsDr Robin K (Katie) Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Mark Yarchoan from the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, Maryland, discuss clinical decision-making with numerous treatment strategies for hepatocellu...
EP 53 | Blood Sugar & Digestion: How Your Gut Affects Your Metabolism and Vice Versa
SIBO Made Simple - March 20, 2024 08:15 - 38 minutes ★★★★★ - 365 ratingsThe podcast is back for a very special two-part bonus episode series dedicated to the subject of carbs and IBS. Which also just so happens to be the subject of my new cookbook! Since the SIBO Made Simple book came out, one big set of questions I keep getting asked from SIBO Amigos and members ...
Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer
CCO Oncology Podcast - March 18, 2024 14:38 - 36 minutesIn this podcast episode, Sara M. Tolaney, MD, MPH, and Melinda Telli, MD, delve into the critical aspects of the current therapeutic landscape for patients with unresectable or metastatic HER2-low, hormone receptor–positive, and triple-negative breast cancer, including: Challenges with the path...
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
Gastrointestinal Cancer Update - March 07, 2024 17:48 - 1 hour ★★★★ - 17 ratingsDr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss the management of gastroesophageal cancers and review emerging data sets in the field.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
Gastrointestinal Cancer Update - March 07, 2024 17:48 - 1 hour ★★★★★ - 4 ratingsDr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss the management of gastroesophageal cancers and review emerging data sets in the field.
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
Gastrointestinal Cancer Update - March 07, 2024 17:48 - 1 hour ★★★ - 1 ratingDr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss the management of gastroesophageal cancers and review emerging data sets in the field.
Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
Gastrointestinal Cancer Update - February 23, 2024 18:04 - 1 hour ★★★★ - 17 ratingsDr Ahmed Omar Kaseb from the University of Texas MD Anderson Cancer Center in Houston, Texas, and Prof Arndt Vogel from Schwartz Reisman Liver Research Centre in Toronto, Ontario, discuss the optimal selection and sequencing of checkpoint inhibitor therapy for patients with hepatobiliary cancers.
Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
Gastrointestinal Cancer Update - February 23, 2024 18:04 - 1 hour ★★★★★ - 4 ratingsDr Ahmed Omar Kaseb from the University of Texas MD Anderson Cancer Center in Houston, Texas, and Prof Arndt Vogel from Schwartz Reisman Liver Research Centre in Toronto, Ontario, discuss the optimal selection and sequencing of checkpoint inhibitor therapy for patients with hepatobiliary cancers.
Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
Gastrointestinal Cancer Update - February 23, 2024 18:04 - 1 hour ★★★ - 1 ratingDr Ahmed Omar Kaseb from the University of Texas MD Anderson Cancer Center in Houston, Texas, and Prof Arndt Vogel from Schwartz Reisman Liver Research Centre in Toronto, Ontario, discuss the optimal selection and sequencing of checkpoint inhibitor therapy for patients with hepatobiliary cancers.
Current Considerations for Adverse Event Management With HER3-Directed Agents
CCO Oncology Podcast - December 26, 2023 19:43 - 12 minutesThe third and final episode in a 3-part series covers the safety profile of and considerations for managing adverse events associated with HER3-targeted antibody–drug conjugates, including patritumab deruxtecan (HER3-DXd) and others, in the setting of lung cancer. Presenters in this series inc...
Related Gastrointestinal Topics
- Oncology 4
- Cancer 4
- Colon 3
- Gastroenterology 2